Apple ResearchKit (Part 1): Introduction & Capabilities 2

Photo by Wilfred Iven from stocksnap.io

Photo by Wilfred Iven from stocksnap.io

“Any sufficiently advanced technology is indistinguishable from magic.” – Arthur C. Clarke

Apple has a knack for making technology that, to paraphrase Arthur C. Clarke, feels a bit magical. It turns out that’s the sort of technology people strongly prefer to use. As a result, Apple has built a loyal consumer following, suggesting that commitment to a delightful technology experience is simply good business. Professionals in all industries have taken note of Apple’s success, and clinical research professionals are no exception.

I and others working in clinical innovation have looked to Apple for inspiration on how we might use technology to improve the patient experience. How can we make research participation more delightful and less frustrating? How can we distill a very complex process into an experience that feels very simple for research participants? How can we make clinical research more…Apple-like? Now we won’t have to look much further for potential answers. Apple itself is seeking to answer these questions.

Apple recently announced ResearchKit, creating waves far beyond the clinical research community. ResearchKit is an open-source framework that provides researchers and application developers with a platform to build mobile study apps. Apple’s announcement was accompanied by the release of five ResearchKit-built apps. Because the ResearchKit framework integrates multiple capabilities into one platform, researchers have a single destination to conduct research. And patients have a single destination to participate in research, simply by downloading any chosen study app onto their mobile device.

More…

The Lilly COI API and TrialReach: A Story of Innovation 19

tomThe following blog post is by Tom Krohn. Tom is the Chief Development Officer for TrialReach and is responsible for business development including clinical trial sponsor relationships, patient advocacy groups and research institutions. He has 25 years of experience across different sectors in health including large pharma, hospital & retail pharmacy, and the developing world. Most recently, Tom led the Clinical Open Innovation team at Eli Lilly with a focus on patient engagement, open data and business transformation. Tom is passionate about serving patients from their point-of-view while building sustainable and highly effective organizations.

Everyone Has a Story

Everyone has a story.  You.  Me.  Innovation.

About four years ago, a small group of Lilly employees started work on open innovation with a focus on improving public information to accelerate medical innovation. Barry Crist and I wrote a whitepaper that outlined a vision for clinical knowledge generation becoming participatory for all in the clinical research ecosystem, especially patients.  Participatory—that is the essence of an open network. It is at the core of open innovation.

With executive sponsorship and a case for action, we took these ideas and developed an open API which launched in 2012. We put Creative Commons copyleft licensing on the API to remove the friction that is the norm of the life-science industry. Then, open innovation happened.

More…

What is Informed Consent in Clinical Trials? 1

Imagine for a moment you are a patient considering clinical trial participation. Or perhaps you really are considering clinical trial participation (good for you)! Either way, let’s say you want to understand more about informed consent in clinical trials. If you are like most patients today, you’ll look to a search engine for answers. So go ahead and do that. Head to your favorite search engine and type “informed consent clinical trials.” I’ll wait right here for you to return.

What did you find in the search results?

Here is what we noticed. First, patients have to filter through a lot of information to find what they need. They might find regulatory documents intended for research professionals mixed in with introductory content about informed consent. Second, the introductory content available is primarily static text. This static text is helpful, but it’s not as rich or engaging as it would be if accompanied by visual or interactive media. In short, it’s not easy for patients to educate themselves about informed consent in clinical trials.

Click the image to view the interactive infographic.

Click the image to view the interactive infographic.

More…

C.H.E.E.R.s to Clinical Trial Volunteers! 1

Photo by Ryan McGuire from Gratisography.com

Photo by Ryan McGuire from Gratisography.com

Enrolling in a clinical trial is a courageous decision. Research volunteers often take on a significant amount of inconvenience and burden in order to participate. And, unfortunately, they are rarely thanked enough for their contributions to modern medicine. The Center for Information & Study on Clinical Research Participation (CISCRP) notes that many participants report feeling “no longer valued” by research staff after the conclusion of their trial.

To help give clinical trial participants more of the recognition they deserve HealthiVibePartners in Research, the I’m In Campaign, the Coalition for Clinical Trials Awareness, and PhRMA have planned a series of activities to take place during Clinical Trials Awareness Week (May 4 – 8).

There are three ways you can help celebrate clinical trial participants and bring awareness to clinical research:

  • Give a shout out to a clinical research hero through social media using the hashtag #iCHEER4u
  • Log on to the Clinical Trial Participation Google Hangout on May 6 from 3:00 – 3:30 p.m. Eastern Time.
  • Participate in the Clinical Trial Awareness Week tweet chat on May 7 from 2:00 – 3:00 p.m. Eastern Time. Use the hashtag #CTAW.

More…